Page last updated: 2024-11-04

sk&f 86002 and Anasarca

sk&f 86002 has been researched along with Anasarca in 2 studies

6-(4-fluorophenyl)-2,3-dihydro-5-(4-pyridinyl)imidazo(2,1-b)thiazole: inhibits p38 MAP kinase

Research Excerpts

ExcerptRelevanceReference
"SK&F 86002 [6-(4-fluorophenyl)2,3-dihydro-5-(4-pyridinyl)imidazo (2,1-b)thiazole], a dual inhibitor of arachidonic acid metabolism, administered orally to rats prevented the development of carrageenan-induced edema, immune- and nonimmune-mediated inflammation of adjuvant-induced arthritis (AA) and reduced established inflammation in AA and collagen type II-induced arthritis."3.67Pharmacologic characterization of the antiinflammatory properties of a new dual inhibitor of lipoxygenase and cyclooxygenase. ( Berkowitz, BA; DiMartino, MJ; Griswold, DE; Hanna, N; Poste, G, 1987)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Griswold, DE2
Hoffstein, S1
Marshall, PJ1
Webb, EF1
Hillegass, L1
Bender, PE1
Hanna, N2
DiMartino, MJ1
Berkowitz, BA1
Poste, G1

Other Studies

2 other studies available for sk&f 86002 and Anasarca

ArticleYear
Inhibition of inflammatory cell infiltration by bicyclic imidazoles, SK&F 86002 and SK&F 104493.
    Inflammation, 1989, Volume: 13, Issue:6

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Chemotaxis, Leukocyte; Cyclophosphamide; Dinoprost

1989
Pharmacologic characterization of the antiinflammatory properties of a new dual inhibitor of lipoxygenase and cyclooxygenase.
    Agents and actions, 1987, Volume: 20, Issue:1-2

    Topics: Administration, Oral; Analgesia; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experi

1987